COc1cc(S(=O)(=O)Nc2ccc(-c3csc(N4C(=O)C(Cl)C4c4cccc(Oc5ccccc5)c4)n3)cc2)ccc1Cl
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?